Limoneira Company (LMNR)’s director John Merriman Sold 210 Shares of the Company; Eam Investors Increased Revance Therapeutics (RVNC) Holding

John Merriman, an insider and also director of the leading company Limoneira Co made stocks unload. He made a sale of 210 shares of the company with the insider sale transaction having a market value near $4,547 U.S. Dollars – calculated based on $21.7 for a share. Right now, John Merriman has in hand 2,000 shares or about 0.01% of Limoneira Co’s market cap.

Eam Investors Llc increased Revance Therapeutics Inc. (RVNC) stake by 113.94% reported in 2017Q3 SEC filing. Eam Investors Llc acquired 38,621 shares as Revance Therapeutics Inc. (RVNC)’s stock declined 1.67%. The Eam Investors Llc holds 72,518 shares with $2.00 million value, up from 33,897 last quarter. Revance Therapeutics Inc. now has $1.22 billion valuation. The stock increased 0.59% or $0.2 during the last trading session, reaching $33.95. About 265,758 shares traded. Revance Therapeutics, Inc. (NASDAQ:RVNC) has risen 20.40% since January 19, 2017 and is uptrending. It has outperformed by 3.70% the S&P500.

Since August 23, 2017, it had 0 insider purchases, and 4 insider sales for $1.20 million activity. $519,031 worth of Revance Therapeutics, Inc. (NASDAQ:RVNC) shares were sold by Browne L Daniel. On Thursday, October 12 the insider SILVERNAIL LAUREN P sold $297,760.

Investors sentiment decreased to 1 in Q3 2017. Its down 0.96, from 1.96 in 2017Q2. It dropped, as 12 investors sold RVNC shares while 25 reduced holdings. 8 funds opened positions while 29 raised stakes. 27.21 million shares or 0.30% less from 27.29 million shares in 2017Q2 were reported. Parametric Assoc Limited Co holds 35,047 shares or 0% of its portfolio. Goldman Sachs Gru accumulated 0% or 184,880 shares. Rhumbline Advisers reported 25,603 shares. 19,293 were reported by Granite Inv Prtnrs Limited Com. Blackrock reported 2.17 million shares. Rhenman & Prtnrs Asset accumulated 246,400 shares or 0.87% of the stock. Wellington Mgmt Group Llp has 2.34 million shares. Savings Bank Of Mellon accumulated 2.01M shares or 0.02% of the stock. First Personal Ser has 0% invested in Revance Therapeutics, Inc. (NASDAQ:RVNC) for 808 shares. State Street Corp holds 0% or 466,097 shares in its portfolio. Credit Suisse Ag accumulated 24,373 shares. 3,150 are owned by Tower (Trc). Geode Ltd Liability Co stated it has 0% in Revance Therapeutics, Inc. (NASDAQ:RVNC). 3.29M were reported by Franklin Resources. Northern accumulated 0% or 290,950 shares.

Among 11 analysts covering Revance Therapeutics (NASDAQ:RVNC), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. Revance Therapeutics had 24 analyst reports since August 22, 2015 according to SRatingsIntel. The firm has “Buy” rating by Cantor Fitzgerald given on Thursday, November 16. The stock of Revance Therapeutics, Inc. (NASDAQ:RVNC) earned “Hold” rating by Zacks on Saturday, August 22. The rating was maintained by Cantor Fitzgerald on Tuesday, October 24 with “Buy”. As per Tuesday, July 25, the company rating was maintained by Piper Jaffray. SunTrust maintained the shares of RVNC in report on Friday, December 8 with “Buy” rating. The rating was maintained by SunTrust with “Buy” on Thursday, November 2. The rating was initiated by Barclays Capital on Monday, November 27 with “Buy”. The firm has “Buy” rating by Mizuho given on Wednesday, December 6. The stock has “Buy” rating by Piper Jaffray on Tuesday, December 5. On Monday, November 23 the stock rating was initiated by Guggenheim with “Buy”.

Eam Investors Llc decreased Xpo Logistics Inc. (NYSE:XPO) stake by 37,752 shares to 28,772 valued at $1.95M in 2017Q3. It also reduced Lpl Financial Holdings Inc. (NASDAQ:LPLA) stake by 14,654 shares and now owns 48,639 shares. Willdan Group Inc. (NASDAQ:WLDN) was reduced too.

Limoneira Company operates as an agribusiness and real estate development firm in the United States and internationally. The company has market cap of $307.40 million. The firm operates through six divisions: Fresh Lemons, Lemon Packing, Avocados, Other Agribusiness, Rental Operations, and Real Estate Development. It has a 50.81 P/E ratio. The Fresh Lemons segment markets and sells lemons directly to food service, wholesale, and retail customers.

Among 4 analysts covering Limoneira (NASDAQ:LMNR), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Limoneira has $26.5000 highest and $23 lowest target. $25.13’s average target is 17.76% above currents $21.34 stock price. Limoneira had 5 analyst reports since September 10, 2015 according to SRatingsIntel. The company was initiated on Monday, October 19 by Buckingham Research. The rating was maintained by Roth Capital on Thursday, September 10 with “Buy”. The stock of Limoneira Company (NASDAQ:LMNR) earned “Buy” rating by Roth Capital on Wednesday, June 7. TH Capital maintained Limoneira Company (NASDAQ:LMNR) on Thursday, September 10 with “Buy” rating. As per Wednesday, January 11, the company rating was maintained by Lake Street.

Since September 1, 2017, it had 0 insider purchases, and 5 insider sales for $260,389 activity. The insider Sawyer Robert M sold 1,250 shares worth $26,863. Michaelis Ronald L also sold $33,285 worth of Limoneira Company (NASDAQ:LMNR) shares. Edwards Harold S also sold $153,013 worth of Limoneira Company (NASDAQ:LMNR) on Thursday, October 5. Shares for $11,856 were sold by CHESS ELIZABETH BLANCHARD.

The stock increased 2.74% or $0.57 during the last trading session, reaching $21.34. About 27,667 shares traded. Limoneira Company (NASDAQ:LMNR) has risen 20.88% since January 19, 2017 and is uptrending. It has outperformed by 4.18% the S&P500.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: